Cargando…
Hyperammonemia Associated with Valproic Acid Concentrations
Valproic acid, a branched short-chain fatty acid, has numerous action mechanisms which turn it into a broad spectrum anticonvulsant drug and make its use possible in some other pathologies such as bipolar disorder. It is extensively metabolized in liver, representing β-oxidation in the mitochondria...
Autores principales: | Vázquez, Marta, Fagiolino, Pietro, Maldonado, Cecilia, Olmos, Ismael, Ibarra, Manuel, Alvariza, Silvana, Guevara, Natalia, Magallanes, Laura, Olano, Ivette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020540/ https://www.ncbi.nlm.nih.gov/pubmed/24868521 http://dx.doi.org/10.1155/2014/217269 |
Ejemplares similares
-
L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report
por: Maldonado, Cecilia, et al.
Publicado: (2017) -
Lamotrigine-Valproic Acid Interaction Leading to Stevens–Johnson Syndrome
por: Vázquez, Marta, et al.
Publicado: (2018) -
Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects
por: Guevara, Natalia, et al.
Publicado: (2017) -
Population Pharmacokinetics of Clozapine and Norclozapine and Switchability Assessment between Brands in Uruguayan Patients with Schizophrenia
por: Olmos, Ismael, et al.
Publicado: (2019) -
Development of a Population Pharmacokinetic Model for Cyclosporine from Therapeutic Drug Monitoring Data
por: Umpiérrez, Martín, et al.
Publicado: (2021)